Advantages | Disadvantages |
Secured gas exchange | Abnormal blood flow distribution Greater flow to muscle than GI or hepatic circulations |
Guaranteed cardiac ouput | Inflammatory pathway activation |
MAP control by changing flow & vascular resistance | Embolic damage |
Can provide pulsatile or continuous flow | Coagulopathy |
Allows control of body temperature | Errors e.g. mechanical or human (rare) |
Principles of Cardiopulmonary Bypass
Principles of Cardiopulmonary Bypass
Resources
- Cardiopulmonary bypass (CPB) has allowed surgeons to operate in a relatively bloodless field whilst still achieving organ perfusion
- The morbidity and mortality for routine cardiac cases is <5% and CPB is not directly implicated in the majority of these cases
The circuitry itself
- Modern CPB often involves the use of minimised circuits (MiECC), characterised by:
- Small priming volumes (e.g. approx. 600ml vs. historic 1800ml)
- Tip-to-tip coating of the contact surfaces
- Closed systems
- Use of centrifugal pumps (instead of roller pumps)
- Avoidance of cardiotomy suction and vents, using mechanical salvage of red blood cells
- Contact of blood with the circuit induces a systemic inflammatory response and coagulation system activation involving leucocytes, platelets and complement
- Said response is reduced by coating the circuit and oxygenator with a biocompatible material such as heparin, phosphorylcholine or PMEA
- Gas emboli within the circuitry contribute to neurological complications of CPB
- The circuitry is thus completely de-aired before surgery, e.g. with a CO2 flush, in order to reduce neurocognitive impairment from such gaseous microemboli
- The circuitry is also primed prior to use
- Use of crystalloid and colloid solutions is associated with haemodilution, coagulopathy and extravasation of fluid
- Minimising the circuit-prime volumes, and using autologous priming, helps reduce the haematological impact of priming
Venous side
- Deoxygenated blood drains from the right heart, by gravity, into the venous reservoir
- Inadequate venous flow risks air entrainment, and may be due to air locks, kinks in or clamps on the tubing, or poor cannula placement
- Shed blood describes blood taken from cardiotomy suction, pleural or pericardial vents/drains, or the wounds
- Historically it was pumped into a cardiotomy (shed blood) reservoir before being mixed into the venous reservoir and thus into the CPB machine
- This blood is, however, highly activated by the negative pressure on the suction lines and blood-air interfaces
- This state is associated with activation of both the clotting cascade and inflammatory pathways
- Reinfusion is shed blood is associated with neurological injury, cognitive decline and acute lung injury
- Therefore in modern CPB shed blood is handled using a cell salvage machine, reducing the pathological activation of the blood, before returning it
- In the venous reservoir, deoxygenated blood is mixed with filtered shed blood
- This mixed blood is pumped through a heat exchanger, and then into the oxygenator (gas exchanger)
Oxygenator (gas exchanger)
- A hollow-fibre, microporous membrane system is used to oxygenate blood from the venous side of the circuit
- The system has a relatively high intrinsic resistance, hence requiring blood to be pumped through
- Modern oxygenators have a reduced area of blood-gas interface (a source of inflammatory response) and are extremely efficient
- Gas exchange occurs according to Fick's law of diffusion:
- K = diffusion constant
- A = area for diffusion
- ΔC = concentration gradient
- D = distance of diffusion
- Compared to the lungs, oxygenators have a lower surface area (3.5m2vs. 100m2) and greater distance of diffusion (200μm vs. 10μm)
- As such, they rely on higher pressure gradients (e.g. up to 760mmHg i.e. 100kPa) to ensure gas exchange
Rate ∝ KA(ΔC)/D
Arterial side
- Oxygenated blood leaves the gas exchanger and passes through an aortic filter
- A combination of screen filtration and depth filtration is used to minimise:
- Embolic load (solid, gaseous and fat), which is associated with organ injury including cognitive dysfunction
- Inflammatory response by using a leucocyte-depleting filter
- Oxygenated blood then passes into the aorta, distal to the aortic cross-clamp, and is thus pumped through the systemic circulation
Monitoring
- Perfusionists rely on a range of monitoring and safety devices:
Monitoring and safety devices during CPB |
Mixed venous blood saturation monitors (SvO2) |
Real-time (continuous) in-line blood gas analysers both pre- and post-oxygenator |
Oxygenator arterial outlet temperature monitoring |
Regional cerebral tissue oxygenation using NIRS |
Line pressure monitors |
Emergency bypass routes |
Manual control of rotary pumps |
Ports facilitating sampling and addition of fluids/components |
- Opening of the venous line allows passive flow to the venous reservoir
- As venous flow increases, the aortic flow will be gradually increased to ∽2.5L/min
- The target flow is historically estimated using BSA and temperature, although lean body mass may be a more sensitive estimate of systemic metabolic requirements
- Measurements of DO2 provided by the CPB machine need to incorporate [Hb] and SaO2, which may help further determine the requisite pump flow
- Once suitable pump flow is acheived, CPB is fully established and ventilation of the lungs can cease
- The heart is usually completely emptied by CPB, but this mayn't occur until after aortic cross-clamping e.g. in severe AR or presence of shunts
- Even pulsatile CPB flow leads to a low pulse pressure, so MAP is a more accurate variable to monitor
- Target MAP is usually 50-80mmHg
Hypotension
- Blood pressure inevitably falls at the onset of CPB due to:
- Loss of venous return
- Vasoplegic syndrome
- Vasoplegic syndrome describes a reduced SVR due to pro-inflammatory mediator release, anaesthetic drugs and other perioperative drugs e.g. calcium channel blockers
- Prolonged vasoplegia is less common than previously owing to advances in CPB circuit technology and techniques
- This period of low pressure is often short-lived, and MAP can be maintained through:
- Vasoconstrictors e.g. perfusionists will use higher-strength phenylephrine (500μg - 1mg doses) to increase vascular resistance
- Alterations of pump flow, which are a more rapid way of temporarily reducing MAP for surgical needs
- Use of goal-directed haemodynamic therapy once off CPB to maintain DO2
Hypertension
- Hypertension on CPB may derive from:
- Inadequate anaesthesia/analgesia
- Catecholamine release
- Hypothermia-induced vasoconstriction
- Management is with treatment of the underlying cause and use of arterial vasodilators
Temperature control
- Hypothermia is often instigated
- The beneficial effect comes from reduced systemic and cerebral oxygen consumption
- This increases tolerance to the low-flow/low-MAP state during CPB
- Deep hypothermic cardiac arrest (DHCA) is sometimes used for complex aortic or congenital cardiac surgery
- See: dedicated page on temperature management during CPB
Acid-base and electrolytes
- Acid-base status, electrolytes and blood sugar are monitored on a continuous (or at least half-hourly) basis during CPB
- Metabolic acidosis risks tissue injury and organ dysfunction
- It arises due to:
- Tissue hypoxia
- Electrolyte imbalance
- Excessive use of 0.9% NaCl or unbalanced colloids
- In order to reduce post-operative complications associated with acid-base and electrolyte disturbance, recommendations are:
- In cases of mild-moderate hypothermia (i.e. not DHCA), interpretation of acid-base status using alpha-stat blood gases
- Maintain pH 7.35-7.45
- Consider use of magnesium sulphate for arrhythmia prophylaxis
- Severe metabolic injury and deranged kidney function may benefit from intra-operative haemofiltration
Blood products
- Haematological variables including ACT, Hb and haematocrit are measured on a half-hourly basis
- See: dedicated page on anticoagulation during CPB
- Anti-fibrinolytics are often given, either:
- Tranexamic acid e.g. 5-6g in divided doses - often for lower risk or elective cases
- Aprotinin e.g. up to 5,000,000units in divided doses - often for high bleeding risk cases, dissections etc. as the benefit outweighs the risks from aprotinin
- pRBCs are recommended for:
- Hb <60g/L or if inadequate DO2 in conjunction with indices of oxygenation (such as SvO2 and O2 extraction ratio)
- Hct <25% and inadequate tissue oxygenation
- Patients will have cell-saved blood returned to them at the end of bypass
- Patients often require clotting factors or other products at the end of bypass, which are titrated according to point of care tests including TEG/ROTEM
- These include:
- Prothrombin complex concentrate such as octaplex (factors II, VII, IX and X, protein C and protein S) e.g. 500-1500IU
- Fresh frozen plasma (factors II, V, VIII, IX, X, and XI, and antithrombin III)
- Others such as cryoprecipitate less commonly
- Although systemic hypothermia is cerebro-protective, the myocardium is typically not part of the bypass circuit and requires protection via different means
- The main techniques used are:
- Cardioplegic arrest
- Cross-clamp-fibrillation
Cardioplegic arrest
- A solution of predominantly potassium, as well as other elecltrolytes, is used to arrest the heart in diastole, improving operative conditions
- It is typically cooled to 4°C but may be warmed
- It can be administered anterogradely or retrogradely
- See: dedicated page on cardioplegia
Cross-clamp-fibrillation
- Intermittent cross-clamping of the aorta and subsequent myocardial ventricular fibrillation (spontaneous on cross-clamping or by use of a DC fibrillating device)
- Fibrillation can only be safely tolerated for 10 - 15mins so only suitable for quick procedures
- At the end of the period, the cross-clamp is removed and the heart defibrillated into sinus rhythm
- At decreased temperature, such as during CPB, there is an increased solubility of gases in blood, most notably CO2
- Therefore measurement of CO2 and pH at low temperature requires caution
- This leads to two methods for measuring blood gases during CPB: pH-stat and ɑ-stat
pH-stat
- In pH-stat, the pH is kept constant at 7.4 by addition of CO2 to the oxygenator and blood gas parameters are corrected by temperature
- The pH is measured at the actualy patient temperature, giving a relative hypercarbia
- Using pH-stat blood gas management increases CO2 content during cooling
- As cerebral blood flow is controlled by PCO2, pH-stat tends to lead to cerebral vasodilation and an increase in CBF
- Autoregulation, however, is lost and CBF becomes pressure-dependent
- This leads to better cerebral cooling but risk of increased micro-emboli load
ɑ-stat
- ɑ-stat measures blood gas variables inc. pH at a constant 37°C, without the addition of CO2, and alkalosis is permitted during cooling
- ɑ-stat blood gas readings are interpreted uncorrected for body temperature
- Using ɑ-stat may normalise, or reduce, the CBF with the consequence of reduced efficiency of cerebral cooling
- In most centres the ɑ-stat is used, as the majority of post-operative neurological injury is caused by micro- and macro-emboli
- In the paediatric population, however, the pH-stat is often used as the hypoperfusing effect is more dominant with regards to neurological outcome
- Some centres use pH-stat on cooling but ɑ-stat on re-warming
- A multi-disciplinary effort requiring adequate communication between the perioperative team
- Use of a checklist is recommended
Criteria for CPB weaning
Criteria | Notes |
Lung ventilation re-established | Re-expansion & resumption of ventilation |
De-airing of cardiac chambers & grafts (particularly LA/LV) | Aided by TOE |
Aortic cross-clamp removed | Restores coronary artery (and graft) blood flow |
HR and rhythm compatible with weaning | May require epicardial pacing esp. if prolonged CPB or existing conduction defects |
Need for inotropy/IABP considered | Target MAP >60mmHg, no one inotrope known to be superior |
Normothermia (36 - 37°C) | Both hypothermia and hyperthermia are harmful |
Normal electrolytes and acid-base balance | May necessitate use of bicarbonate |
Adequate Hb and Hct | Should be maintained throughout CPB |
Haemodynamic instability post-CPB
- As the aortic cross-clamp is removed, may need vasoactive support to combat ventricular dysfunction or vasoplegia, both of which are common following CPB
- Low cardiac output states are associated with:
- ↑ morbidity
- Higher short-term and long-term mortality
- ↑ resource utilisation
- Management is to correct the cause (e.g. graft dysfunction, hypovolaemia) and use of positive inotropy, or vasopressors, as indicated
- Options for vasopressor support include noradrenaline (1st line), vasopressin, methyline blue or high-dose hydroxycobalamin
- Options for inotropic support include dopamine, milrinone, low-dose adrenaline or IABP
Predictors of requiring vasopressor support | Predictors of requiring inotropic support |
Use of ACE-I or other vasodilators pre-operatively | Poor LVEF or known heart failure |
Septic patient | Symptoms of heart failure e.g. SOBOE, oedema |
High intra-operative phenylephrine requirement | Multiple heart failure medications |
↑ duration of CPB (as greater SIRS response) | ↑ duration of cross-clamping |
Residual ischaemic heart disease e.g. not possible to undertake all planned grafts | |
MVR for mitral regurgitation; the sudden ↑ in LV afterload may precipitate failure |